HRMY
Harmony Biosciences Holdings
39.60$
+0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | +230.9% | +91.6% | +20.0% | +23.4% | +6.0% | +23.7% | +9.4% | +13.0% | -6.5% | +25.5% | +9.5% | +9.5% | -7.2% | +12.7% | +19.4% | +5.1% | -8.2% | +11.8% | +7.7% | +8.2% | -8.2% | +8.5% | +19.4% | +1.8% | -11.6% | +21.3% | – | |
| – | – | – | – | +120.3% | +85.8% | +22.2% | +25.7% | +5.0% | +21.9% | +15.1% | +22.0% | -17.4% | +28.6% | +21.3% | +17.1% | -22.7% | +20.3% | +29.1% | +33.6% | -36.3% | +17.0% | +33.1% | +27.2% | -41.2% | +19.3% | +56.3% | +14.9% | -35.1% | +42.0% | – | |
| – | – | – | – | +270.4% | +92.8% | +19.6% | +22.9% | +6.2% | +24.1% | +8.2% | +11.0% | -3.8% | +24.8% | +7.0% | +7.6% | -3.0% | +11.0% | +17.2% | -2.1% | +1.5% | +10.6% | +1.8% | +2.5% | +4.0% | +6.3% | +10.8% | -2.5% | -2.5% | +15.9% | – | |
| – | -90.6% | -13.2% | +67.8% | -52.8% | +21.5% | +1.5% | +80.1% | -38.6% | +38.9% | +80.7% | -36.5% | +1.7% | +67.2% | +220.1% | -75.1% | +31.7% | +12.6% | +16.9% | +73.2% | -26.8% | +186.6% | -60.1% | +36.6% | -0.4% | +45.2% | +9.6% | -9.1% | +39.0% | -32.8% | – | |
| – | +48.7% | +113.2% | +11.4% | -33.6% | -17.9% | +37.8% | +28.1% | +8.0% | -1.7% | +17.9% | +8.0% | -1.8% | +24.0% | -3.8% | +6.2% | -2.6% | +3.4% | -1.2% | +23.6% | -7.9% | +6.0% | +5.0% | +1.0% | +8.2% | +8.6% | -12.1% | +93.1% | -43.5% | -13.7% | – | |
| – | -69.5% | +54.7% | +27.9% | -31.8% | -6.7% | +12.8% | +41.2% | -10.0% | +8.9% | +19.2% | -0.7% | -3.9% | +27.8% | +49.7% | -34.7% | +7.6% | +7.6% | +1.9% | +34.0% | -11.7% | +58.9% | -31.7% | +11.7% | +5.9% | +18.3% | +0.1% | +19.6% | -2.3% | -18.6% | – | |
| – | – | – | – | – | – | +42.0% | -25.3% | +87.3% | +60.4% | -9.7% | +36.0% | -3.8% | +20.2% | -64.1% | +300.1% | -15.1% | +16.0% | +37.5% | -37.7% | +29.4% | -59.0% | +189.0% | -9.7% | +0.9% | -14.3% | +35.9% | -41.1% | -3.3% | +139.5% | – | |
| – | – | +54.8% | +31.1% | +132.0% | +8.9% | +0.1% | +14.7% | -10.5% | +1.4% | -24.0% | -22.6% | -0.4% | -1.2% | +17.9% | -27.3% | +59.9% | +8.5% | +12.8% | -31.6% | -5.4% | -2.9% | -1.3% | -3.2% | -8.9% | -5.0% | -0.7% | -2.1% | -8.8% | -4.8% | – | |
| – | – | – | – | – | – | – | -110.9% | – | +117.8% | -165.4% | – | -4.5% | +25.0% | -72.7% | +453.6% | -14.3% | +16.7% | +17.5% | -23.4% | +30.5% | -58.1% | +186.6% | -9.7% | +1.8% | -13.2% | +36.0% | -39.6% | -2.6% | +135.0% | – | |
| – | – | – | – | – | -76.1% | -21.8% | -180.9% | – | -72.3% | -145.7% | – | +7.9% | +200.0% | -1,503.1% | – | – | +18.1% | +36.5% | -2.2% | +2.8% | -24.9% | +59.1% | -58.4% | +73.9% | -15.1% | +68.6% | +9.9% | -60.6% | +147.7% | – | |
| – | – | – | – | – | – | – | -110.9% | – | +91.1% | -168.1% | – | -5.4% | +9.5% | +273.7% | -44.8% | -39.2% | +16.3% | +12.1% | -30.8% | +44.1% | -69.8% | +297.7% | +7.3% | -7.9% | -12.7% | +27.9% | -55.8% | +44.5% | +132.2% | – | |
| – | – | – | – | – | – | +32.6% | -1.7% | +58.1% | +46.1% | -101.5% | – | +351.1% | +19.7% | -54.0% | +198.3% | -7.8% | +13.7% | +15.2% | -5.7% | +2.0% | -48.5% | +125.5% | -8.5% | +1.0% | -11.5% | +24.0% | -29.6% | -5.5% | +109.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.